No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Wellgistics Health Files to Sell 3.57M Shares of Common Stock for Holders
Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion With Over 350 New Pharmacies Added to Its Nationwide Network
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
Wellgistics Health Inc Appoints New Chief Financial Officer
Wellgistics Appoints Mark DiSiena As CFO
Wellgistics Names Mark DiSiena as New CFO
